859 related articles for article (PubMed ID: 30851391)
21. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
[TBL] [Abstract][Full Text] [Related]
22. Biodegradable polymers for targeted delivery of anti-cancer drugs.
Doppalapudi S; Jain A; Domb AJ; Khan W
Expert Opin Drug Deliv; 2016 Jun; 13(6):891-909. PubMed ID: 26983898
[TBL] [Abstract][Full Text] [Related]
23. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
[TBL] [Abstract][Full Text] [Related]
24. Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications.
Sgorla D; Bunhak ÉJ; Cavalcanti OA; Fonte P; Sarmento B
Expert Opin Drug Deliv; 2016 Sep; 13(9):1301-9. PubMed ID: 27110648
[TBL] [Abstract][Full Text] [Related]
25. Recent applications of PLGA based nanostructures in drug delivery.
Mir M; Ahmed N; Rehman AU
Colloids Surf B Biointerfaces; 2017 Nov; 159():217-231. PubMed ID: 28797972
[TBL] [Abstract][Full Text] [Related]
26. A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability.
Sithole MN; Choonara YE; du Toit LC; Kumar P; Pillay V
Pharm Dev Technol; 2017 Mar; 22(2):283-295. PubMed ID: 27470222
[TBL] [Abstract][Full Text] [Related]
27. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticulate Drug Delivery to Colorectal Cancer: Formulation Strategies and Surface Engineering.
Tran TT; Tran PH; Wang Y; Li P; Kong L
Curr Pharm Des; 2016; 22(19):2904-12. PubMed ID: 26898738
[TBL] [Abstract][Full Text] [Related]
29. Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery.
Xie Z; Su Y; Kim GB; Selvi E; Ma C; Aragon-Sanabria V; Hsieh JT; Dong C; Yang J
Small; 2017 Mar; 13(10):. PubMed ID: 28026115
[TBL] [Abstract][Full Text] [Related]
30. A Polymeric Bowl for Multi-Agent Delivery.
Hyun DC
Macromol Rapid Commun; 2015 Aug; 36(16):1498-504. PubMed ID: 26033149
[TBL] [Abstract][Full Text] [Related]
31. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.
Chen MC; Sonaje K; Chen KJ; Sung HW
Biomaterials; 2011 Dec; 32(36):9826-38. PubMed ID: 21925726
[TBL] [Abstract][Full Text] [Related]
32. Polymeric protective agents for nanoparticles in drug delivery and targeting.
Mogoşanu GD; Grumezescu AM; Bejenaru C; Bejenaru LE
Int J Pharm; 2016 Aug; 510(2):419-29. PubMed ID: 26972379
[TBL] [Abstract][Full Text] [Related]
33. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
Cheng R; Meng F; Deng C; Klok HA; Zhong Z
Biomaterials; 2013 May; 34(14):3647-57. PubMed ID: 23415642
[TBL] [Abstract][Full Text] [Related]
34. Applications of polymeric nanocapsules in field of drug delivery systems.
Rong X; Xie Y; Hao X; Chen T; Wang Y; Liu Y
Curr Drug Discov Technol; 2011 Sep; 8(3):173-87. PubMed ID: 21644922
[TBL] [Abstract][Full Text] [Related]
35. An Appraisal on Various Methods of Nano Particulate Formulations.
Dhiman B; Divtrannum ; Dhiman A; Saini S
Pharm Nanotechnol; 2017; 5(4):255-262. PubMed ID: 29119943
[TBL] [Abstract][Full Text] [Related]
36. Dry Powder form of Polymeric Nanoparticles for Pulmonary Drug Delivery.
Shiehzadeh F; Tafaghodi M
Curr Pharm Des; 2016; 22(17):2549-60. PubMed ID: 26818872
[TBL] [Abstract][Full Text] [Related]
37. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
Narang AS; Chang RK; Hussain MA
J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
[TBL] [Abstract][Full Text] [Related]
38. Advanced drug and gene delivery systems based on functional biodegradable polycarbonates and copolymers.
Chen W; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
J Control Release; 2014 Sep; 190():398-414. PubMed ID: 24858708
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary drug delivery: a role for polymeric nanoparticles?
d'Angelo I; Conte C; Miro A; Quaglia F; Ungaro F
Curr Top Med Chem; 2015; 15(4):386-400. PubMed ID: 25579350
[TBL] [Abstract][Full Text] [Related]
40. Designing polymer conjugates as lysosomotropic nanomedicines.
Duncan R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]